Real-world outcomes of SGLT2 inhibitors in kidney transplant recipients with post-transplant diabetes mellitus: An effectiveness and safety analysis

Diabetes Epidemiology and Management · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles